Nautilus Biotechnology, Inc. (NAUT) — Operating Cash Flow
| Fiscal Year | Operating Cash Flow | Change YoY |
|---|---|---|
| 2025 | -$50.70M | +14.3% |
| 2024 | -$59.15M | -14.4% |
| 2023 | -$51.71M | -12.9% |
| 2022 | -$45.81M | -16.7% |
| 2021 | -$39.24M | -180.4% |
| 2020 | -$14.00M | — |
| Fiscal Year | Operating Cash Flow | Change YoY |
|---|---|---|
| 2025 | -$50.70M | +14.3% |
| 2024 | -$59.15M | -14.4% |
| 2023 | -$51.71M | -12.9% |
| 2022 | -$45.81M | -16.7% |
| 2021 | -$39.24M | -180.4% |
| 2020 | -$14.00M | — |